HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health And Wellness Market News: Nestle Invests In Amazentis, CBD Launches, More

Executive Summary

PepsiCo promotes Steven Williams to CEO of North American division; Nestle invests in Amazentis to create supplements with its natural bioactive that improves mitochondrial function; Anlit introduces probiotic chews for women; CBD topical pain relief from Omax; more news.

You may also be interested in...



Swiss Firm Amazentis' Supplement With Urolithin A For Age-Related Muscle Decline Debuts In US

Nestle-backed Amazentis says clinical studies show its Timeline Cellular Nutrition delivers “significant” improvement in muscle strength after four months and delivers six times more urolithin A than pomegranate juice. Direct-to-consumer sales currently are available only in the US.

Functional Beverage Brands Mark Soda Giants' Footprint In Healthy Future

Dr. Pepper Snapple and PepsiCo purchase functional beverage brands Bai Brands and KeVita, respectively, to position for growth in the booming healthy drink segment, which is outpacing soda sales growth.

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148698

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel